Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Initial Management of Diarrhea with Negative Shiga Toxin Test

Assessment and Evaluation

  • The Infectious Diseases Society of America recommends evaluating patients with diarrhea for dehydration, which increases the risk of life-threatening illness and death, especially among young children and older adults 1, 2
  • Assess for fever, bloody or mucoid stools, severe abdominal cramping or tenderness, or signs of sepsis, which may indicate specific bacterial pathogens requiring targeted treatment 3
  • Consider clinical and epidemiological features that may suggest specific pathogens, such as recent travel history 2, food consumption patterns (raw/undercooked meat, seafood, unpasteurized dairy) 4, exposure to others with similar symptoms 1, and recent antibiotic use 1, 4

Diagnostic Approach

  • The Infectious Diseases Society of America recommends further stool testing for other common bacterial pathogens including Salmonella, Shigella, Campylobacter, Yersinia, and C. difficile in patients with a negative Shiga toxin test 3
  • Blood cultures should be obtained from infants <3 months of age 5, patients with signs of septicemia 1, immunocompromised individuals 1, and those with systemic manifestations of infection 3, 5
  • Consider specific testing based on clinical presentation, such as testing for Yersinia in patients with persistent abdominal pain 3 and testing for Vibrio species in patients with large-volume rice water stools or exposure to seafood/brackish waters 3

Treatment Algorithm

  • The American Academy of Pediatrics and the World Health Organization recommend fluid and electrolyte replacement as the cornerstone of management for patients with diarrhea 6, 7
  • For mild to moderate dehydration, use reduced osmolarity oral rehydration solution (ORS) 6
  • For severe dehydration, shock, altered mental status, or failure of oral rehydration therapy, administer isotonic intravenous fluids (lactated Ringer's or normal saline) 6, 7

Special Considerations

  • If symptoms persist beyond 14 days, consider non-infectious conditions including inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) 5
  • Follow-up testing is not recommended in most people following resolution of diarrhea 5
  • For patients who do not respond to initial therapy, clinical and laboratory reevaluation may be indicated 5

Common Pitfalls to Avoid

  • Failing to distinguish between non-Shiga toxin E. coli and Shiga toxin-producing E. coli (STEC) when interpreting test results 6, 7
  • Inadequate fluid replacement, especially in high-risk populations like young children and elderly patients 2, 7